These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2403792)
21. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Jackson KW; Allbert JR; Schemmer GK; Elliot M; Humphrey A; Taylor J Am J Obstet Gynecol; 2001 Oct; 185(4):873-7. PubMed ID: 11641669 [TBL] [Abstract][Full Text] [Related]
22. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. Mitchell GG; Elbourne DR Online J Curr Clin Trials; 1993 Aug; Doc No 83():[2305 words; 32 paragraphs]. PubMed ID: 8306013 [TBL] [Abstract][Full Text] [Related]
23. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial. King KJ; Douglas MJ; Unger W; Wong A; King RA Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945 [TBL] [Abstract][Full Text] [Related]
24. Recurrent inversion of the puerperal uterus managed with 15(s)-15-methyl prostaglandin F2 alpha and uterine packing. Heyl PS; Stubblefield PG; Phillippe M Obstet Gynecol; 1984 Feb; 63(2):263-4. PubMed ID: 6607434 [TBL] [Abstract][Full Text] [Related]
25. Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue. Hayashi RH; Castillo MS; Noah ML Obstet Gynecol; 1984 Jun; 63(6):806-8. PubMed ID: 6610143 [TBL] [Abstract][Full Text] [Related]
26. Induction of abortion by intramuscular administration of (15S)-15-methyl PGF2 alpha. An overview of 815 cases. Schwallie PC; Lamborn KR J Reprod Med; 1979 Dec; 23(6):289-93. PubMed ID: 392084 [TBL] [Abstract][Full Text] [Related]
27. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. George RB; McKeen D; Chaplin AC; McLeod L Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255 [TBL] [Abstract][Full Text] [Related]
28. [Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial]. Fekih M; Jnifene A; Fathallah K; Ben Regaya L; Memmi A; Bouguizene S; Chaieb A; Bibi M; Khairi H J Gynecol Obstet Biol Reprod (Paris); 2009 Nov; 38(7):588-93. PubMed ID: 19833454 [TBL] [Abstract][Full Text] [Related]
29. Local administration of (15 S)-15-methyl PGF2 alpha for management of hypotonic post-partum hemorrhage. Thiery M; Parewijck W Z Geburtshilfe Perinatol; 1985; 189(4):179-80. PubMed ID: 3876658 [TBL] [Abstract][Full Text] [Related]
30. [Some aspects of prostaglandin administration in obstetrics: preliminary report]. Marinov B; Andreeva A; Cankova M Akush Ginekol (Sofiia); 2011; 50 Suppl 2():34-5. PubMed ID: 22524138 [TBL] [Abstract][Full Text] [Related]
31. [Pulmonary edema related to administration of 15-methyl-prostaglandin F2alpha during a cesarean section]. Rodríguez de la Torre MR; Gallego Alonso JI; Gil Fernández M Rev Esp Anestesiol Reanim; 2004 Feb; 51(2):104-7. PubMed ID: 15072404 [TBL] [Abstract][Full Text] [Related]
32. Second-line uterotonics and the risk of hemorrhage-related morbidity. Butwick AJ; Carvalho B; Blumenfeld YJ; El-Sayed YY; Nelson LM; Bateman BT Am J Obstet Gynecol; 2015 May; 212(5):642.e1-7. PubMed ID: 25582104 [TBL] [Abstract][Full Text] [Related]
33. A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean delivery. Bai J; Sun Q; Zhai H Exp Ther Med; 2014 Jan; 7(1):46-50. PubMed ID: 24348762 [TBL] [Abstract][Full Text] [Related]
34. Use of 15-methyl prostaglandin F2 alpha postpartum to contract the uterus in normal pregnant women. Nelson GH J Med Assoc Ga; 1983 Oct; 72(10):703-6. PubMed ID: 6644193 [No Abstract] [Full Text] [Related]
35. [Intramuscular administration of Prostin for abortion in the second trimester]. Curić F; Vilendecić R Jugosl Ginekol Opstet; 1984; 24(3-4):68-70. PubMed ID: 6503343 [TBL] [Abstract][Full Text] [Related]
36. Uterine contraction pattern as a predictor of the mode of delivery. Oppenheimer LW; Bland ES; Dabrowski A; Holmes P; McDonald O; Wen SW J Perinatol; 2002 Mar; 22(2):149-53. PubMed ID: 11896521 [TBL] [Abstract][Full Text] [Related]
37. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Rath W Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358 [TBL] [Abstract][Full Text] [Related]
38. The effect of placental removal method and site of uterine repair on postcesarean endometritis and operative blood loss. Baksu A; Kalan A; Ozkan A; Baksu B; Tekelioğlu M; Goker N Acta Obstet Gynecol Scand; 2005 Mar; 84(3):266-9. PubMed ID: 15715535 [TBL] [Abstract][Full Text] [Related]
39. The effect of co-administration of intravenous calcium chloride and oxytocin on maternal hemodynamics and uterine tone following cesarean delivery: a double-blinded, randomized, placebo-controlled trial. Farber MK; Schultz R; Lugo L; Liu X; Huang C; Tsen LC Int J Obstet Anesth; 2015 Aug; 24(3):217-24. PubMed ID: 25935422 [TBL] [Abstract][Full Text] [Related]
40. Carboprost trometamol in the management of the third stage of labor. Abdel-Aleem H; Abol-Oyoun EM; Moustafa SA; Kamel HS; Abdel-Wahab HA Int J Gynaecol Obstet; 1993 Sep; 42(3):247-50. PubMed ID: 7901080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]